Total Payments
$354,052
2024 Payments
$38.71
Companies
14
Transactions
292
Medicare Patients
113
Medicare Billing
$13,078
Payment Breakdown by Category
Other$259,725 (73.4%)
Travel$81,965 (23.2%)
Consulting$7,200 (2.0%)
Food & Beverage$4,913 (1.4%)
Education$248.36 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $259,725 | 82 | 73.4% |
| Travel and Lodging | $81,965 | 121 | 23.2% |
| Consulting Fee | $7,200 | 2 | 2.0% |
| Food and Beverage | $4,913 | 79 | 1.4% |
| Education | $248.36 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $260,451 | 202 | $0 (2020) |
| Celgene Corporation | $61,831 | 42 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $27,981 | 29 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,950 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $873.72 | 4 | $0 (2017) |
| GENZYME CORPORATION | $350.00 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $300.00 | 1 | $0 (2020) |
| Genentech, Inc. | $210.00 | 5 | $0 (2017) |
| TESARO, Inc. | $26.44 | 2 | $0 (2019) |
| Tempus AI, Inc | $23.87 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.71 | 2 | Tempus AI, Inc ($23.87) |
| 2023 | $32.70 | 2 | Celgene Corporation ($18.49) |
| 2021 | $22,460 | 24 | JAZZ PHARMACEUTICALS INC. ($22,434) |
| 2020 | $7,847 | 10 | Jazz Pharmaceuticals Inc. ($5,547) |
| 2019 | $90,633 | 73 | Genentech USA, Inc. ($90,606) |
| 2018 | $139,008 | 99 | Genentech USA, Inc. ($88,123) |
| 2017 | $94,033 | 82 | Genentech USA, Inc. ($80,071) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 02/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.87 | General |
| 08/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Hematology | ||||||
| 11/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/03/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $840.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/01/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $108.54 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/29/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/18/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $103.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/13/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/07/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,780.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/25/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/23/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $266.58 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/23/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $138.96 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/23/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $138.96 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/22/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $119.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/20/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $221.60 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/19/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $122.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/18/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $42.86 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/18/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $22.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/13/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $950.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/13/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $97.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/06/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | Cash or cash equivalent | $446.79 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/08/2021 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 27 | $7,317 | $1,760 |
| 2022 | 2 | 28 | 60 | $14,710 | $3,443 |
| 2021 | 1 | 14 | 28 | $7,588 | $2,275 |
| 2020 | 4 | 54 | 92 | $20,943 | $5,601 |
Total Patients
113
Total Services
207
Medicare Billing
$13,078
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 27 | $7,317 | $1,760 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 29 | $7,859 | $1,918 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 31 | $6,851 | $1,525 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 28 | $7,588 | $2,275 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 43 | $11,653 | $2,663 | 22.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 25 | $4,550 | $1,484 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $4,140 | $1,351 | 32.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Facility | 2020 | 11 | 12 | $600.00 | $102.93 | 17.2% |
About Sanjay Jain, MD,PHD
Sanjay Jain, MD,PHD is a Hematology & Oncology healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619919750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sanjay Jain, MD,PHD has received a total of $354,052 in payments from pharmaceutical and medical device companies, with $38.71 received in 2024. These payments were reported across 292 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($259,725).
As a Medicare-enrolled provider, Jain has provided services to 113 Medicare beneficiaries, totaling 207 services with total Medicare billing of $13,078. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology
- Location Riverdale, GA
- Active Since 06/12/2006
- Last Updated 06/18/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1619919750
Products in Payments
- TECENTRIQ (Biological) $167,811
- Abraxane (Drug) $52,021
- ZEPZELCA (Drug) $27,981
- Alecensa (Biological) $15,574
- FASLODEX (Drug) $1,950
- KISQALI (Drug) $873.72
- JEVTANA (Drug) $350.00
- LIBTAYO (Biological) $300.00
- ZEJULA (Drug) $26.44
- Pomalyst (Drug) $18.49
- CONTRAVE (Drug) $14.84
- KEYTRUDA (Biological) $14.21
- VRAYLAR (Drug) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.